28 Ott PA, Hu- Lieskovan S, Chmielowski B, et al. A phase IB trial of personalized Neoantigen therapy plus anti- PD- 1 in patients with advanced Melanoma, non- small cell lung cancer, or bladder cancer. Cell 2020;183:347–62. 29 Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus Ipilimumab in advanced Melanoma. N Engl J Med 2013;369:122–33.